XML 78 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations and Divestitures - Narrative (Details)
SFr / shares in Units, shares in Millions, SFr in Millions, $ in Millions, ¥ in Billions
3 Months Ended 9 Months Ended
Oct. 01, 2020
USD ($)
Apr. 01, 2019
USD ($)
Jan. 17, 2019
USD ($)
Jan. 17, 2019
JPY (¥)
Sep. 27, 2020
USD ($)
shares
Sep. 27, 2020
CHF (SFr)
shares
Mar. 29, 2020
USD ($)
Sep. 29, 2019
USD ($)
Mar. 31, 2019
USD ($)
Sep. 27, 2020
USD ($)
Sep. 29, 2019
USD ($)
Sep. 27, 2020
CHF (SFr)
SFr / shares
Dec. 29, 2019
USD ($)
Jan. 16, 2019
Business Acquisition [Line Items]                            
Goodwill         $ 34,307         $ 34,307     $ 33,639  
Contingent consideration         636         636     $ 1,715  
Reversal of contingent consideration                   1,148 $ 0      
Asset write-downs                   198 1,019      
Other (income) expense, net         (1,200)     $ (4,214)   (545) $ (2,509)      
bermekimab                            
Business Acquisition [Line Items]                            
Business acquisition cost             $ 800              
Intangible assets             800              
Verb Surgical Inc.                            
Business Acquisition [Line Items]                            
Intangible assets             400              
Goodwill             200              
Other assets             200              
Liabilities assumed             300              
Fair value of previously held equity investment             400              
Auris Health                            
Business Acquisition [Line Items]                            
Business acquisition cost   $ 3,400                        
Intangible assets   3,000                        
Goodwill   2,000                        
Liabilities assumed   1,800                        
Contingent consideration   2,350                        
Marketable securities   200                        
Reversal of contingent consideration                   1,148        
Auris Health | Purchased In-Process Research And Development                            
Business Acquisition [Line Items]                            
Asset write-downs         100                  
Ci:z Holdings Co. Ltd.                            
Business Acquisition [Line Items]                            
Business acquisition cost     $ 2,100 ¥ 230                    
Intangible assets             1,500              
Goodwill             1,200              
Liabilities assumed             400              
Foreign exchange rate                           109.06
Other (income) expense, net                 $ 300          
Adjustments made to intangible assets             $ 100              
Weighted average useful life             15 years 3 months 18 days              
Momenta [Member] | Subsequent Event                            
Business Acquisition [Line Items]                            
Business acquisition cost $ 6,500                          
AdvancedSterilizationProducts                            
Business Acquisition [Line Items]                            
Gain from divestiture of business   2,000                        
Discontinued Operations, Held-for-sale or Disposed of by Sale | Supply Chain                            
Business Acquisition [Line Items]                            
Assets held for sale, current         $ 100         100        
Discontinued Operations, Held-for-sale or Disposed of by Sale | AdvancedSterilizationProducts                            
Business Acquisition [Line Items]                            
Disposal group consideration   2,800                        
Disposal group consideration, cash   2,700                        
Receivables retained   $ 100                        
Idorsia                            
Business Acquisition [Line Items]                            
Shares issued in transaction (in shares) | shares         11.8 11.8                
Percentage ownership before transaction         8.30% 8.30%                
Gross proceeds on sale         $ 357 SFr 337                
Sales price per share (in CHF per share) | SFr / shares                       SFr 28.55    
Ownership interest after sale | shares         38.7 38.7                
Percentage ownership after transaction         20.00% 20.00%                
Idorsia | Convertible Debt | Idorsia                            
Business Acquisition [Line Items]                            
Long-term debt | SFr                       SFr 445    
Idorsia | Idorsia | Line of Credit | Revolving Credit Facility                            
Business Acquisition [Line Items]                            
Line of credit | SFr                       SFr 243    
Other Income | Auris Health                            
Business Acquisition [Line Items]                            
Reversal of contingent consideration                   $ 1,100